BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 38446042)

  • 21. Diagnostic accuracy of biparametric vs multiparametric MRI in clinically significant prostate cancer: Comparison between readers with different experience.
    Di Campli E; Delli Pizzi A; Seccia B; Cianci R; d'Annibale M; Colasante A; Cinalli S; Castellan P; Navarra R; Iantorno R; Gabrielli D; Buffone A; Caulo M; Basilico R
    Eur J Radiol; 2018 Apr; 101():17-23. PubMed ID: 29571792
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Cascaded Deep Learning-Based Artificial Intelligence Algorithm for Automated Lesion Detection and Classification on Biparametric Prostate Magnetic Resonance Imaging.
    Mehralivand S; Yang D; Harmon SA; Xu D; Xu Z; Roth H; Masoudi S; Sanford TH; Kesani D; Lay NS; Merino MJ; Wood BJ; Pinto PA; Choyke PL; Turkbey B
    Acad Radiol; 2022 Aug; 29(8):1159-1168. PubMed ID: 34598869
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adversarial training for prostate cancer classification using magnetic resonance imaging.
    Hu L; Zhou DW; Guo XY; Xu WH; Wei LM; Zhao JG
    Quant Imaging Med Surg; 2022 Jun; 12(6):3276-3287. PubMed ID: 35655831
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prostate Cancer Differentiation and Aggressiveness: Assessment With a Radiomic-Based Model vs. PI-RADS v2.
    Chen T; Li M; Gu Y; Zhang Y; Yang S; Wei C; Wu J; Li X; Zhao W; Shen J
    J Magn Reson Imaging; 2019 Mar; 49(3):875-884. PubMed ID: 30230108
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bi-parametric magnetic resonance imaging based radiomics for the identification of benign and malignant prostate lesions: cross-vendor validation.
    Ji X; Zhang J; Shi W; He D; Bao J; Wei X; Huang Y; Liu Y; Chen JC; Gao X; Tang Y; Xia W
    Phys Eng Sci Med; 2021 Sep; 44(3):745-754. PubMed ID: 34075559
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Deep Learning Reconstruction Enables Highly Accelerated Biparametric MR Imaging of the Prostate.
    Johnson PM; Tong A; Donthireddy A; Melamud K; Petrocelli R; Smereka P; Qian K; Keerthivasan MB; Chandarana H; Knoll F
    J Magn Reson Imaging; 2022 Jul; 56(1):184-195. PubMed ID: 34877735
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Establishment and prospective validation of an SUV
    Jiao J; Kang F; Zhang J; Quan Z; Wen W; Zhao X; Ma S; Wu P; Yang F; Guo W; Yang X; Yuan J; Shi Y; Wang J; Qin W
    Theranostics; 2021; 11(17):8396-8411. PubMed ID: 34373749
    [No Abstract]   [Full Text] [Related]  

  • 28. Semi-automatic classification of prostate cancer on multi-parametric MR imaging using a multi-channel 3D convolutional neural network.
    Aldoj N; Lukas S; Dewey M; Penzkofer T
    Eur Radiol; 2020 Feb; 30(2):1243-1253. PubMed ID: 31468158
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Avoiding Unnecessary Biopsy: MRI-based Risk Models versus a PI-RADS and PSA Density Strategy for Clinically Significant Prostate Cancer.
    Deniffel D; Healy GM; Dong X; Ghai S; Salinas-Miranda E; Fleshner N; Hamilton R; Kulkarni G; Toi A; van der Kwast T; Zlotta A; Finelli A; Perlis N; Haider MA
    Radiology; 2021 Aug; 300(2):369-379. PubMed ID: 34032510
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Deep transfer learning-based prostate cancer classification using 3 Tesla multi-parametric MRI.
    Zhong X; Cao R; Shakeri S; Scalzo F; Lee Y; Enzmann DR; Wu HH; Raman SS; Sung K
    Abdom Radiol (NY); 2019 Jun; 44(6):2030-2039. PubMed ID: 30460529
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development and Validation of Interpretable Machine Learning Models for Clinically Significant Prostate Cancer Diagnosis in Patients With Lesions of PI-RADS v2.1 Score ≥3.
    Ruan M; Liu Y; Yao K; Wang K; Fan Y; Wu S; Wang X
    J Magn Reson Imaging; 2024 Feb; ():. PubMed ID: 38363125
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Classification of Cancer at Prostate MRI: Deep Learning versus Clinical PI-RADS Assessment.
    Schelb P; Kohl S; Radtke JP; Wiesenfarth M; Kickingereder P; Bickelhaupt S; Kuder TA; Stenzinger A; Hohenfellner M; Schlemmer HP; Maier-Hein KH; Bonekamp D
    Radiology; 2019 Dec; 293(3):607-617. PubMed ID: 31592731
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Machine learning-based radiomics model to predict benign and malignant PI-RADS v2.1 category 3 lesions: a retrospective multi-center study.
    Jin P; Shen J; Yang L; Zhang J; Shen A; Bao J; Wang X
    BMC Med Imaging; 2023 Mar; 23(1):47. PubMed ID: 36991347
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MRI combined with PSA density in detecting clinically significant prostate cancer in patients with PSA serum levels of 4∼10ng/mL: Biparametric versus multiparametric MRI.
    Han C; Liu S; Qin XB; Ma S; Zhu LN; Wang XY
    Diagn Interv Imaging; 2020 Apr; 101(4):235-244. PubMed ID: 32063483
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessing the Clinical Value of Positive Multiparametric Magnetic Resonance Imaging in Young Men with a Suspicion of Prostate Cancer.
    Stabile A; Dell'Oglio P; Soligo M; De Cobelli F; Gandaglia G; Fossati N; Esposito A; Brembilla G; Karnes RJ; Montorsi F; Briganti A
    Eur Urol Oncol; 2021 Aug; 4(4):594-600. PubMed ID: 31204312
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical study of multifactorial diagnosis in prostate biopsy.
    Li J; Wang K; Li S; Wu P; Wang X; He Y; Tang W
    Prostate; 2023 Nov; 83(15):1494-1503. PubMed ID: 37545333
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of a nomogram combining multiparametric magnetic resonance imaging and PSA-related parameters to enhance the detection of clinically significant cancer across different region.
    Zhou Z; Liang Z; Zuo Y; Zhou Y; Yan W; Wu X; Ji Z; Li H; Hu M; Ma L
    Prostate; 2022 Apr; 82(5):556-565. PubMed ID: 35098557
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modified Predictive Model and Nomogram by Incorporating Prebiopsy Biparametric Magnetic Resonance Imaging With Clinical Indicators for Prostate Biopsy Decision Making.
    Pan JF; Su R; Cao JZ; Zhao ZY; Ren DW; Ye SZ; Huang RD; Tao ZL; Yu CL; Jiang JH; Ma Q
    Front Oncol; 2021; 11():740868. PubMed ID: 34589437
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Investigating the equivalent performance of biparametric compared to multiparametric MRI in detection of clinically significant prostate cancer.
    Wang B; Gao J; Zhang Q; Zhang C; Liu G; Wei W; Huang H; Fu Y; Li D; Zhang B; Guo H
    Abdom Radiol (NY); 2020 Feb; 45(2):547-555. PubMed ID: 31907568
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prostate Cancer Risk Stratification in Men With a Clinical Suspicion of Prostate Cancer Using a Unique Biparametric MRI and Expression of 11 Genes in Apparently Benign Tissue: Evaluation Using Machine-Learning Techniques.
    Montoya Perez I; Jambor I; Pahikkala T; Airola A; Merisaari H; Saunavaara J; Alinezhad S; Väänänen RM; Tallgrén T; Verho J; Kiviniemi A; Ettala O; Knaapila J; Syvänen KT; Kallajoki M; Vainio P; Aronen HJ; Pettersson K; Boström PJ; Taimen P
    J Magn Reson Imaging; 2020 May; 51(5):1540-1553. PubMed ID: 31588660
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.